NeoPharm CO., LTD.

KOSDAQ:A092730 株式レポート

時価総額：₩183.1b

NeoPharm 過去の業績

過去 基準チェック /26

NeoPharmは、平均年間3.7%の収益成長を遂げていますが、 Personal Products業界の収益は、年間 成長しています。収益は、平均年間13.8% 5.3%収益成長率で 成長しています。 NeoPharmの自己資本利益率は13.1%であり、純利益率は19.9%です。

主要情報

3.7%

収益成長率

5.7%

EPS成長率

Personal Products 業界の成長3.8%
収益成長率5.3%
株主資本利益率13.1%
ネット・マージン19.9%
前回の決算情報30 Sep 2024

最近の業績更新

We Think That There Are Some Issues For NeoPharm (KOSDAQ:092730) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For NeoPharm (KOSDAQ:092730) Beyond Its Promising Earnings

NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Mar 25
NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Recent updates

We Think That There Are Some Issues For NeoPharm (KOSDAQ:092730) Beyond Its Promising Earnings

Nov 20
We Think That There Are Some Issues For NeoPharm (KOSDAQ:092730) Beyond Its Promising Earnings

The Returns On Capital At NeoPharm (KOSDAQ:092730) Don't Inspire Confidence

Nov 13
The Returns On Capital At NeoPharm (KOSDAQ:092730) Don't Inspire Confidence

NeoPharm CO., LTD.'s (KOSDAQ:092730) Earnings Are Not Doing Enough For Some Investors

Sep 13
NeoPharm CO., LTD.'s (KOSDAQ:092730) Earnings Are Not Doing Enough For Some Investors

NeoPharm (KOSDAQ:092730) Will Want To Turn Around Its Return Trends

Aug 07
NeoPharm (KOSDAQ:092730) Will Want To Turn Around Its Return Trends

NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Jun 13
NeoPharm CO., LTD. (KOSDAQ:092730) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

Apr 24
Benign Growth For NeoPharm CO., LTD. (KOSDAQ:092730) Underpins Its Share Price

NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Mar 25
NeoPharm's (KOSDAQ:092730) Earnings Are Weaker Than They Seem

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Mar 28
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Mar 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

Mar 02
How Much Did NeoPharm's(KOSDAQ:092730) Shareholders Earn From Share Price Movements Over The Last Three Years?

We're Watching These Trends At NeoPharm (KOSDAQ:092730)

Feb 18
We're Watching These Trends At NeoPharm (KOSDAQ:092730)

We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

Feb 08
We're Not So Sure You Should Rely on NeoPharm's (KOSDAQ:092730) Statutory Earnings

NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

Jan 26
NeoPharm CO., LTD. (KOSDAQ:092730) Has Got What It Takes To Be An Attractive Dividend Stock

An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Jan 15
An Intrinsic Calculation For NeoPharm CO., LTD. (KOSDAQ:092730) Suggests It's 31% Undervalued

Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

Jan 04
Will Weakness in NeoPharm CO., LTD.'s (KOSDAQ:092730) Stock Prove Temporary Given Strong Fundamentals?

NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Dec 24
NeoPharm CO., LTD. (KOSDAQ:092730) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Dec 15
What Is NeoPharm CO., LTD.'s (KOSDAQ:092730) Share Price Doing?

Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Dec 04
Does NeoPharm (KOSDAQ:092730) Have A Healthy Balance Sheet?

Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

Nov 23
Would Shareholders Who Purchased NeoPharm's (KOSDAQ:092730) Stock Year Be Happy With The Share price Today?

収支内訳

NeoPharm の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

KOSDAQ:A092730 収益、費用、利益 ( )KRW Millions
日付収益収益G+A経費研究開発費
30 Sep 24112,20022,33438,3693,035
30 Jun 24107,85822,92937,4902,838
31 Mar 24101,73522,51637,3052,690
31 Dec 2397,10523,21336,2762,647
30 Sep 2392,27120,73334,9242,777
30 Jun 2389,29219,78134,1422,739
31 Mar 2386,27218,91233,0872,805
31 Dec 2285,03317,02732,9842,854
30 Sep 2286,80518,24534,6852,898
30 Jun 2287,42417,37035,7903,043
31 Mar 2287,32116,90535,5872,945
31 Dec 2187,93117,71336,0222,935
30 Sep 2186,80218,20735,0872,764
30 Jun 2185,27518,05934,1072,658
31 Mar 2185,28718,47434,5092,880
31 Dec 2081,62518,13132,9912,802
30 Sep 2081,41318,73434,0942,824
30 Jun 2082,61819,93533,9052,768
31 Mar 2082,68019,90133,4072,602
31 Dec 1983,24019,24533,9582,518
30 Sep 1979,61118,00231,0382,550
30 Jun 1974,86316,67529,5622,659
31 Mar 1969,50015,79527,6542,616
31 Dec 1866,27515,37026,2752,576
30 Sep 1863,14313,68226,5922,616
30 Jun 1860,23613,10525,4952,355
31 Mar 1857,17512,51424,5772,257
31 Dec 1753,63411,55923,6262,098
30 Sep 1749,7659,81423,0972,105
30 Jun 1746,7399,36521,3722,068
31 Mar 1743,1648,09619,7262,184
31 Dec 1642,3697,74219,6782,183
30 Sep 1643,0975,95519,9022,206
30 Jun 1641,9995,41919,8312,209
31 Dec 1535,9653,40717,9981,973

質の高い収益: A092730 非現金収入 のレベルが高いです。

利益率の向上: A092730の現在の純利益率 (19.9%)は、昨年(22.5%)よりも低くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: A092730の収益は過去 5 年間で年間3.7%増加しました。

成長の加速: A092730の過去 1 年間の収益成長率 ( 7.7% ) は、5 年間の平均 ( 年間3.7%を上回っています。

収益対業界: A092730の過去 1 年間の収益成長率 ( 7.7% ) Personal Products業界82.1%を上回りませんでした。

株主資本利益率

高いROE: A092730の 自己資本利益率 ( 13.1% ) は 低い とみなされます。

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

7D

1Y

7D

1Y

7D

1Y